Warning! GuruFocus detected
6 Severe warning signs
with OCX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
OncoCyte Corp (NAS:OCX) Stock News, Headlines & Updates
OncoCyte Corp Stock News from GuruFocus
- 1
Apr 02, 2025
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
Marketwired • 8:00am
Mar 28, 2025
Lake Street Initiates Coverage on OncoCyte (OCX) with Buy Rating
GuruFocus News • 10:56am
Mar 25, 2025
OncoCyte Corp (OCX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Regulatory Progress Amid Market Challenges
GuruFocus News • 11:00am
Q4 2024 OncoCyte Corp Earnings Call Transcript
GuruFocus News • 9:00am
Mar 24, 2025
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Marketwired • 4:00pm
OncoCyte Corp Q4 2024 Earnings: Revenue Surges to $1.5 Million, Beating Estimates; EPS at -0.43
GuruFocus News • 3:31pm
Mar 18, 2025
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Marketwired • 4:00pm
Feb 15, 2025
AWM Investment Company, Inc. Increases Stake in OncoCyte Corp
GuruFocus News • 6:43pm
Feb 11, 2025
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Marketwired • 8:00am
Feb 10, 2025
Oncocyte Prices $29.1 Million Equity Offering
Marketwired • 8:00am
Jan 08, 2025
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Marketwired • 8:00am
Jan 06, 2025
Oncocyte Expands Market Opportunity for VitaGraftâ„¢ Kidney
Marketwired • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news